股价史高股舒泰神拟定增募不超12.53亿 连亏五年半

Core Viewpoint - Shuyou Shen (300204.SZ) plans to raise up to RMB 125.3 million through a private placement of shares, with the funds allocated for innovative drug research and working capital [1][2]. Fund Allocation - The total investment for the innovative drug research project is RMB 91.3 million, with RMB 88.3 million expected to be raised from this issuance [2]. - The working capital will receive RMB 37 million from the raised funds [2]. - The total planned investment amounts to RMB 128.3 million, with the issuance expected to cover the majority of this amount [2]. Issuance Details - The issuance will target no more than 35 specific investors, including qualified institutional investors and other eligible entities [2][3]. - The maximum number of shares to be issued is capped at 143,331,766, which is 30% of the company's total shares prior to the issuance [3]. - The shares will be priced at no less than 80% of the average trading price over the 20 trading days preceding the pricing date [3]. Financial Performance - From 2020 to the first half of 2025, the company reported net profits of -RMB 1.33 billion, -RMB 1.37 billion, -RMB 1.97 billion, -RMB 3.99 billion, -RMB 1.45 billion, and -RMB 246.36 million respectively [4]. - The company's revenue for 2021 was RMB 584.29 million, showing a 37.41% increase from 2020, but a decline from 2019 [5]. - In 2024, the revenue was RMB 324.82 million, a decrease of 10.81% from 2023 [6]. - The net profit for 2024 improved to -RMB 144.84 million, a 63.69% increase compared to the previous year [6]. Stock Performance - On August 19, the company's stock price reached an all-time high of RMB 66.66 [6].